Nantahala Capital Management’s scPharmaceuticals SCPH Stock Holding History

Nantahala Capital Management’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-861,277	Closed	-$4.88M	–	170
2025 Q3	$4.88M	Sell	861,277 -134,161	-13%	-$687K	0.17%	106
2025 Q2	$3.79M	Hold	995,438	–	–	0.15%	103
2025 Q1	$2.62M	Sell	995,438 -4,562	-0.5%	-$14.9K	0.1%	104
2024 Q4	$3.54M	Buy	1,000,000 +250,000	+33%	+$958K	0.15%	96
2024 Q3	$3.42M	Buy	+750,000	New	+$3.63M	0.17%	86

Nantahala Capital Management's SCPH Position: Q4 2025 in Review

Nantahala Capital Management sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 861,277 shares — an estimated $4.88M sold.

Nantahala Capital Management first reported a position in SCPH in Q3 2024 and held it in 5 quarters. The position peaked at $4.88M in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Nantahala Capital Management reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Nantahala Capital Management sold 861,277 scPharmaceuticals shares in Q4 2025, an estimated $4.88M.
Nantahala Capital Management first reported a position in scPharmaceuticals in Q3 2024 and held it in 5 quarters.
Nantahala Capital Management's scPharmaceuticals position peaked at $4.88M in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Nantahala Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.